Pharmaceutical intermediates
Eldecalcitol Intermediates
6 pharmaceutical intermediates for Eldecalcitol. Indication: Postmenopausal osteoporosis; Osteoporosis.
About Eldecalcitol
- Originator
- Chugai Pharmaceutical Co., Ltd
- Indication
- Postmenopausal osteoporosis; Osteoporosis
Available intermediates
6 intermediates currently listed for Eldecalcitol. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| de-A,B-25-hydroxycholestan-8β-ol | 66774-84-3 | / | / |
| (1R,3aR,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one | 70550-73-1 | / | / |
| 4H-Inden-4-one, 1-[1,5-dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-, [1R-[1α(R*),3aβ,7aα]]- | 144848-24-8 | / | / |
| Eldecalcitol interMediates | 200636-42-6 | / | / |
| Phosphine oxide, [(2Z)-2-[(3R,4R,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]propoxy]-2-Methylenecyclohexylidene]ethyl]diphenyl- | 200636-54-0 | / | / |
| Phosphine oxide, [(2Z)-2-[(3R,4R,5R)-2-methylene-3,5-bis[(triethylsilyl)oxy]-4-[3-[(triethylsilyl)oxy]propoxy]cyclohexylidene]ethyl]diphenyl- | 2189732-17-8 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →